SPOTLIGHT: Analysts: Continued fast growth for vaccine industry

The vaccine market is revving up for a continued expansion over the next few years, according to new analysis by India's RNCOS. Looking at the global market for vaccines from 2007 to 2010, RNCOS says new pediatric vaccines and the "booming" market for influenza drugs in the U.S. and Europe will lead the way to more growth. Between 2003 and 2006 the U.S. vaccines market grew at a rate of 9.3 percent a year and the analysts say the industry will maintain that pace at least through 2008 as more vaccines coming into the market. The growth is occurring as the number of vaccines makers is shrinking. Just a handful of companies dominate the U.S. market. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.